H.B. Fuller director Thomas Handley buys $98,820 in stock

H.B. Fuller director Thomas W. Handley bought 2,000 FUL shares at $49.41, investing $98,820 as the stock traded near its $46.70 52-week low. The company’s Q3 2026 adjusted EPS of $1.52 beat the $1.47 consensus, but revenue of $938 million missed the $948.25 million estimate amid cautious near-term demand trends. Baird cut its price target to $65 from $75 while retaining an Outperform rating; InvestingPro estimates fair value at $70.56 versus a recent share price of $48.87.

Analysis

The purchase is not a high-conviction valuation signal: its dollar size is immaterial relative to the director's pre-existing economic exposure through deferred equity, and it does not resolve the more important question of whether end-market volumes have bottomed. For FUL, a revenue shortfall despite an EPS beat typically implies that mix, pricing, cost control, or lower incentive compensation carried earnings; those supports are less durable than a return to organic volume growth. The market is likely to require evidence that volume is improving in packaging, hygiene, construction and durable-goods channels before rerating the shares toward peer multiples.

A softer-rate backdrop is directionally helpful but operates with a lag. Residential construction and industrial demand improvement would affect adhesive volumes over the next 2-4 quarters, while lower rates could also reduce interest expense and support free-cash-flow conversion; neither is likely to materially change the next quarterly print. The key second-order risk is that FUL's smaller scale versus Avery Dennison (AVY), DuPont (DD), and Chemours (CC) leaves it with less ability to defend margins if customers demand price concessions as petrochemical inputs ease. Consensus may be overly focused on the dividend and apparent valuation discount rather than the risk that fiscal-2027 earnings estimates still embed a volume recovery not yet visible in reported sales.

Key Decisions for Investors

• Do not chase the insider filing. Keep FUL on a 1-3 month watchlist and only initiate a long after management reports positive organic volume growth or raises full-year sales guidance; the missing data is segment-level volume and price/mix, not another valuation-derived fair-value estimate.
• For a cyclical recovery expression, consider a small long FUL / short AVY pair over 6-12 months only if FUL confirms volume stabilization. FUL offers greater operating leverage to a construction/industrial rebound, while short AVY reduces broad specialty-materials beta; exit if FUL's next two quarterly revenue prints remain below guidance or if adjusted EBITDA margin contracts year-over-year.
• If holding FUL for income, cap position size until leverage and cash conversion are reconfirmed at the next results. A break below the recent cycle low combined with lower fiscal-2027 EPS guidance would indicate that the valuation discount is earnings-driven rather than temporary and should invalidate the recovery thesis.
• Monitor North American housing activity, industrial production, and petrochemical feedstock costs over the next 3-6 months. Improving housing/PMI data with stable inputs is the favorable setup; falling inputs accompanied by continued weak sales would signal customer price pass-through and downside risk to margins.